Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
PHILADELPHIA, PA / ACCESSWIRE / March 28, 2024 / The abrdn U.S. Closed-End Funds (NYSE:ASGI, HQH, HQL, IFN, JEQ, THQ, THW) (NYSE American:IAF), (the "Funds" or individually the "Fund"), today announced that the Funds paid the distributions noted in ...
PHILADELPHIA, PA / ACCESSWIRE / March 21, 2024 / abrdn Healthcare Investors (NYSE:HQH), abrdn Life Sciences Investors (NYSE:HQL), abrdn Healthcare Opportunities Fund (NYSE:THQ), and abrdn World Healthcare Fund (NYSE:THW) (collectively, the "Funds") ...
PHILADELPHIA, PA / ACCESSWIRE / February 9, 2024 / abrdn Life Sciences Investors (HQL), abrdn Healthcare Investors (HQH), and abrdn Healthcare Opportunities Fund (THQ) (collectively, the "Funds") each, a closed-end management investment company, announced ...
PHILADELPHIA, PA / ACCESSWIRE / October 27, 2023 / Effective close of business today, October 27, 2023, abrdn Inc. ("abrdn") assumed responsibility for the management of the four (4) former Tekla Capital Management LLC closed-end funds totaling $2.8bn ...
BOSTON, October 27, 2023--HQH, HQL, THQ, THW
BOSTON, October 27, 2023--Tekla Capital Management LLC (Tekla) announced today that the requisite vote has been attained to approve the new investment advisory agreement with abrdn Inc. for each of its four closed-end funds (the Funds).
BOSTON, October 13, 2023--Tekla Healthcare Investors (HQH) today announced at the Special Meetings of shareholders ("Special Meetings") that the requisite vote had been attained for the proposal to approve the new investment advisory agreement with abrdn Inc.
BOSTON, October 05, 2023--Tekla Life Sciences Investors (HQL) announced at the Joint Special Meetings of shareholders ("Special Meetings") that the requisite vote had been reached to approve the new investment advisory agreement with abrdn Inc.
BOSTON, September 29, 2023--On September 29, 2023, Tekla Healthcare Investors paid a distribution of $0.40 per share. It is currently estimated that this distribution is derived from net realized long-term capital gains. The composition of this and subsequent distributions may vary from quarter to quarter because it may be materially impacted by future realized gains and losses on securities. The aggregate of the net unrealized appreciation of portfolio securities and net realized gains on sale
On September 25, 2023, President Daniel Omstead made a significant investment in Tekla Healthcare Investors (NYSE:HQH), purchasing 9,500 shares of the company's stock.